אינג'י 10 מג80 מג טבליות

Šalis: Izraelis

kalba: hebrajų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

EZETIMIBE; SIMVASTATIN

Prieinama:

MERCK SHARP & DOHME ISRAEL LTD

ATC kodas:

C10AA01

Vaisto forma:

טבליה

Sudėtis:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Vartojimo būdas:

פומי

Recepto tipas:

מרשם נדרש

Pagaminta:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Farmakoterapinė grupė:

SIMVASTATIN

Gydymo sritis:

SIMVASTATIN

Terapinės indikacijos:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Leidimo data:

2012-04-30